DANIEL ROSEN to Biomarkers, Tumor
This is a "connection" page, showing publications DANIEL ROSEN has written about Biomarkers, Tumor.
Connection Strength
0.285
-
CD133 expression associated with poor prognosis in ovarian cancer. Mod Pathol. 2012 Mar; 25(3):456-64.
Score: 0.056
-
Low membranous expression of beta-catenin and high mitotic count predict poor prognosis in endometrioid carcinoma of the ovary. Mod Pathol. 2010 Jan; 23(1):113-22.
Score: 0.049
-
ALDH1 expression correlates with favorable prognosis in ovarian cancers. Mod Pathol. 2009 Jun; 22(6):817-23.
Score: 0.047
-
Loss of annexin A1 expression in breast cancer progression. Appl Immunohistochem Mol Morphol. 2008 Dec; 16(6):530-4.
Score: 0.046
-
Expression of p14ARF, p15INK4b, p16INK4a, and DCR2 increases during prostate cancer progression. Mod Pathol. 2006 Oct; 19(10):1339-43.
Score: 0.039
-
CA-125 level as a prognostic indicator in type I and type II epithelial ovarian cancer. Int J Gynecol Cancer. 2013 Jun; 23(5):815-22.
Score: 0.016
-
AURKA and BRCA2 expression highly correlate with prognosis of endometrioid ovarian carcinoma. Mod Pathol. 2011 Jun; 24(6):836-45.
Score: 0.013
-
Activation of BTAK expression in primary ovarian surface epithelial cells of prophylactic ovaries. Mod Pathol. 2007 Oct; 20(10):1078-84.
Score: 0.010
-
Insulin-like growth factor-binding protein 2 and 5 are differentially regulated in ovarian cancer of different histologic types. Mod Pathol. 2006 Sep; 19(9):1149-56.
Score: 0.010